Cargando…

Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome

Objectives: In recent years several (18)F-labeled amyloid PET (Aβ-PET) tracers have been developed and have obtained clinical approval. There is evidence that Aβ-PET perfusion can provide surrogate information about neuronal injury in neurodegenerative diseases when compared to conventional blood fl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitt, Julia, Palleis, Carla, Sauerbeck, Julia, Unterrainer, Marcus, Harris, Stefanie, Prix, Catharina, Weidinger, Endy, Katzdobler, Sabrina, Wagemann, Olivia, Danek, Adrian, Beyer, Leonie, Rauchmann, Boris-Stephan, Rominger, Axel, Simons, Mikael, Bartenstein, Peter, Perneczky, Robert, Haass, Christian, Levin, Johannes, Höglinger, Günter U., Brendel, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155727/ https://www.ncbi.nlm.nih.gov/pubmed/34054506 http://dx.doi.org/10.3389/fnagi.2021.661284

Ejemplares similares

Impact of Partial Volume Correction on [(18)F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
por: Schuster, Sebastian, et al.
Publicado: (2022)

Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study
por: Beyer, Leonie, et al.
Publicado: (2020)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer’s Disease
por: Kreuzer, Annika, et al.
Publicado: (2021)

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
por: Schönecker, Sonja, et al.
Publicado: (2019)

Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [(18)F]-PI-2620 tau-PET signal
por: Schönecker, Sonja, et al.
Publicado: (2023)

Impact of TSPO Receptor Polymorphism on [(18)F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings
por: Völter, Friederike, et al.
Publicado: (2022)

Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease
por: Beyer, Leonie, et al.
Publicado: (2019)

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
por: Biechele, Gloria, et al.
Publicado: (2020)

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

[(18)F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2018)

Feasibility of short imaging protocols for [(18)F]PI-2620 tau-PET in progressive supranuclear palsy
por: Song, Mengmeng, et al.
Publicado: (2021)

Corticobasal degeneration and corticobasal syndrome: A review
por: Constantinides, Vasilios C., et al.
Publicado: (2019)

Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis
por: Brendel, Matthias, et al.
Publicado: (2017)

The Significance of Vascular Pathogenesis in the Examination of Corticobasal Syndrome
por: Dunalska, Anna, et al.
Publicado: (2021)

Early-phase [(18)F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
por: Beyer, Leonie, et al.
Publicado: (2020)

Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
por: Brendel, Matthias, et al.
Publicado: (2017)

Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
por: Blume, Tanja, et al.
Publicado: (2022)

Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA
por: Brendel, Matthias, et al.
Publicado: (2020)

Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
por: Albrecht, Franziska, et al.
Publicado: (2017)

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation
por: Brendel, Matthias, et al.
Publicado: (2018)

Tau deposition patterns are associated with functional connectivity in primary tauopathies
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition
por: Rauchmann, Boris Stephan, et al.
Publicado: (2021)

Rapidly Progressive Corticobasal Degeneration Syndrome
por: Valverde, Ana Herrero, et al.
Publicado: (2011)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014)

Apraxia and Motor Dysfunction in Corticobasal Syndrome
por: Burrell, James R., et al.
Publicado: (2014)

Corticobasal syndrome: A diagnostic conundrum
por: Parmera, Jacy Bezerra, et al.
Publicado: (2016)

Neuropathology and emerging biomarkers in corticobasal syndrome
por: Koga, Shunsuke, et al.
Publicado: (2022)

Neuronal Antibody-Associated Corticobasal Syndrome
por: Gupta, Anu, et al.
Publicado: (2023)

Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on (18)F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models
por: Nack, Anne, et al.
Publicado: (2019)

[(18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
por: Ballweg, Anna, et al.
Publicado: (2023)

Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease
por: Biechele, Gloria, et al.
Publicado: (2022)

Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice
por: Overhoff, Felix, et al.
Publicado: (2016)

Cross-Sectional Comparison of Small Animal [(18)F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
por: Brendel, Matthias, et al.
Publicado: (2015)

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011)

Brain Perfusion in Corticobasal Syndrome with Progressive Aphasia
por: Abe, Yoshitake, et al.
Publicado: (2016)

Novel GRN Mutations in Patients with Corticobasal Syndrome
por: Taghdiri, Foad, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bk70ap13ef6c7a5hdb569vi2vv